Investor · Durham, NC

Charles Perou

Open Charles in the network graph →

Filings

8

SEC Form D

Connections

68

co-filers

Capital

$4.5M

across filings

Active

Apr 2021

to Jun 2025

Most-connected co-filers (68)

Myla V. Lai-Goldman · Durham, NC8 shared Arnold V. Levine · Durham, NC8 shared Clay Thorp · Malvern, PA8 shared Michael V. Milburn · Durham, NC5 shared Tom War · West Linn, OR4 shared Christopher R. Welch · WOODMERE, OH2 shared John M. Corcoran · Boston, MA2 shared Ronald C. Hess, Jr · WOODMERE, OH2 shared Mitchell Ginsberg · Scottsdale, AZ2 shared Robertson G. Mansi · Boston, MA2 shared Alan Schnaid · Scottsdale, AZ2 shared Anne Marie W. Bernard · Boston, MA2 shared Michael W. Roberge · Boston, MA2 shared Aaron C. Davis · WOODMERE, OH2 shared Gregory B. Rieker · Boulder, CO2 shared Michael S. Keenan · Boston, MA2 shared Carol W. Geremia · Boston, MA2 shared Robert J. Wright · Boulder, CO2 shared Marc Mirbod · Scottsdale, AZ2 shared Jason Atwood · West Linn, OR2 shared John F. Bookout Iii · Boulder, CO2 shared Charuda G. Upatham-Costello · Boston, MA2 shared Ian R. Dickinson · Boulder, CO2 shared Sean C. Coburn · Boulder, CO2 shared

Recent filings (8)

GeneCentric Therapeutics, Inc.Jun 2025 · 18 co-filers$5.0M GeneCentric Therapeutics, Inc.Sep 2022 · 16 co-filers$3.5M PRIMUS CAPITAL FUND IX-A, LPMay 2021 · 17 co-filers$750.0M PRIMUS CAPITAL FUND IX, LPMay 2021 · 17 co-filers$750.0M MFS Emerging Markets Debt LLC IMay 2021 · 22 co-filers MFS Global Aggregate Opportunistic LLCApr 2021 · 22 co-filers GeneCentric Therapeutics, Inc.Jan 2021 · 16 co-filers$1.2M GeneCentric Therapeutics, Inc.Jan 2021 · 16 co-filers$1.2M GeneCentric Diagnostics, Inc.Jan 2017 · 14 co-filers$8.6M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Charles in the interactive graph →